Waters Stock (NYSE:WAT)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$331.31

52W Range

$231.90 - $367.21

50D Avg

$319.54

200D Avg

$319.90

Market Cap

$19.52B

Avg Vol (3M)

$411.75K

Beta

0.95

Div Yield

-

WAT Company Profile


Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

7,900

IPO Date

Nov 17, 1995

Website

WAT Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Ta Service$101.95M$93.18M$87.18M
Ta Instrument Systems$252.88M$252.31M$225.61M
Service$1.05B--
Product$1.90B$1.99B$1.82B
Chemistry Consumables$541.47M--
Waters Service$951.42M$890.61M$876.63M
Waters Instrument Systems$1.11B$1.21B$1.09B

Fiscal year ends in Dec 23 | Currency in USD

WAT Financial Summary


Dec 23Dec 22Dec 21
Revenue$2.96B$2.97B$2.79B
Operating Income$861.54M$873.39M$821.71M
Net Income$642.23M$707.75M$692.84M
EBITDA$1.03B$1.02B$975.75M
Basic EPS$10.84$11.80$11.25
Diluted EPS$10.84$11.73$11.17

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q2 24Jul 31, 24 | 2:30 PM
Q1 24May 07, 24 | 12:00 AM
Q4 23Feb 06, 24 | 12:50 PM

Peer Comparison


TickerCompany
RVTYRevvity, Inc.
TMOThermo Fisher Scientific Inc.
IQVIQVIA Holdings Inc.
DHRDanaher Corporation
IDXXIDEXX Laboratories, Inc.
ICLRICON Public Limited Company
TWSTTwist Bioscience Corporation
CRLCharles River Laboratories International, Inc.
MTDMettler-Toledo International Inc.
ILMNIllumina, Inc.
SHCSotera Health Company